MedPath
NMPA Approval

Crizotinib Capsules

国药准字HJ20171012

February 10, 2022

H20171012

Drug Information

克唑替尼胶囊

赛可瑞

胶囊剂

200mg

化学药品

February 10, 2022

February 9, 2027

Company Information

Applicant Company

Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Manufacturing Company

pfizer manufacturing deutschland gmbh, betriebsstatte freiburg

Mooswaldallee 1, 79090 Freiburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

克唑替尼胶囊 - NMPA 批准文号 | MedPath